Hoth Therapeutics' Exercise of Warrants Raises $4.2 Million, Fueling Innovation in Biopharmaceutical Space
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross ProceedsNEW YORK, March 27, 2024 - Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, recently made a significant...
Mar 27, 2024
• Major Pharmaceutical Preparations Industry
Stock Offering
NASDAQ
